• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Probl Cardiol . Impact of COVID-19 on Outcomes of Patients Hospitalized with STEMI: A Nationwide Propensity-Matched Analysis

tetano

Editor, Senior Moderator
Curr Probl Cardiol


. 2022 Dec 14;101547.
doi: 10.1016/j.cpcardiol.2022.101547. Online ahead of print.
Impact of COVID-19 on Outcomes of Patients Hospitalized with STEMI: A Nationwide Propensity-Matched Analysis


Akshay Goel[SUP] 1 [/SUP], Aaqib H Malik[SUP] 2 [/SUP], Dhrubajyoti Bandyopadhyay[SUP] 2 [/SUP], Ameesh Isath[SUP] 2 [/SUP], Rahul Gupta[SUP] 3 [/SUP], Adrija Hajra[SUP] 4 [/SUP], Rishi Shrivastav[SUP] 5 [/SUP], Salim S Virani[SUP] 6 [/SUP], Gregg C Fonarow[SUP] 7 [/SUP], Carl J Lavie[SUP] 8 [/SUP], Srihari S Naidu[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction: Patients with ST-segment elevation myocardial infarction (STEMI) and concurrent coronavirus disease 2019 (COVID-19) have been reported to have poor outcomes. However, previous studies are small and limited.
Methods: The National Inpatient Sample (NIS) database for the year 2020 was queried to identify all adult hospitalizations with a primary diagnosis of STEMI, with and without concurrent COVID-19. A 1:1 propensity score matching was performed.
Results: A total of 159,890 hospitalizations with a primary diagnosis of STEMI were identified. Of these, 2,210 (1.38%) had concurrent COVID-19. After propensity matching, STEMI patients with concurrent COVID-19 had a significantly higher mortality (17.8% vs 9.1%, OR 1.96, p <0.001), lower likelihood to receive same-day percutaneous coronary intervention (PCI) (63.6% vs 70.6%, p = 0.019), with a trend towards lower overall PCI (74.9% vs 80.2%, p = 0.057) and significantly lower coronary artery bypass grafting (CABG) (3.0% vs 6.8%, p = 0.008) prior to discharge, compared with STEMI patients without COVID-19. The prevalence of cardiogenic shock, need for mechanical circulatory support, extracorporeal membrane oxygenation (ECMO), cardiac arrest, acute kidney injury (AKI), dialysis, major bleeding and stroke were not significantly different between the groups. COVID-19-positive STEMI patients who received same-day PCI had significantly lower odds of in-hospital mortality (adjusted OR 0.42, 95% CI 0.20-0.85, p = 0.017).
Conclusion: STEMI patients with concurrent COVID-19 infection had a significantly higher (almost two times) in-hospital mortality, and lower likelihood of receiving same-day PCI, overall (any-day) PCI, and CABG during their admission, compared with STEMI patients without COVID-19.

Keywords: COVID-19; STEMI; myocardial infarction.
 
Back
Top Bottom